The OPA1-dependent mitochondrial cristae remodeling pathway controls atrophic, apoptotic, and ischemic tissue damage

Area of Science:

• Mitochondrial biology
• Cellular stress response
• Tissue homeostasis

Background:

• Mitochondrial morphology changes during apoptosis and autophagy.
• The in vivo relevance of these changes for tissue damage response is not well understood.
• The optic atrophy 1 (OPA1) protein is involved in mitochondrial cristae remodeling.

Purpose of the Study:

• To investigate the in vivo role of the OPA1-dependent cristae remodeling pathway.
• To determine if this pathway regulates tissue response to various damage stimuli.
• To elucidate the mechanisms by which OPA1 impacts tissue damage.

Main Methods:

• Genetic inhibition of the OPA1-dependent cristae remodeling pathway in mice.
• Assessment of tissue response to denervation-induced muscular atrophy.
• Evaluation of protection against ischemic heart and brain damage.
• Analysis of hepatocellular apoptosis.
• Measurement of mitochondrial respiratory efficiency, cytochrome c release, and reactive oxygen species production.

Main Results:

• Genetic inhibition of the OPA1 pathway did not affect normal development.
• Mice lacking functional OPA1 pathway were protected from denervation-induced muscle atrophy.
• Mice were also protected from ischemic heart and brain damage.
• Hepatocellular apoptosis was reduced in mice with inhibited OPA1 pathway.
• OPA1-dependent cristae stabilization enhanced mitochondrial respiratory efficiency and reduced mitochondrial dysfunction, cytochrome c release, and ROS production.

Conclusions:

• The OPA1-dependent cristae remodeling pathway is a fundamental regulator of tissue response to damage in vivo.
• This pathway protects against multiple forms of tissue injury, including apoptosis, necrosis, and atrophy.
• The OPA1 pathway represents a targetable determinant of tissue damage.